ByteDance spin-off Anew Labs raises US$290m as AI drug developers enjoy fundraising boom

AI Funding & IPOs (Google News)September 17, 2026en

AI Funding & IPOs (Google News)

AI Global Wire

As AI's role in drug design advances rapidly, Chinese start-ups are ramping up fundraising efforts China is seeing a fresh fundraising boom for AI drug developers, with start-ups including a ByteDance ...

This is a short summary published by AI Global Wire. The full article is owned and hosted by AI Funding & IPOs (Google News) — open it there to read it in full.

• Företag